Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch<sup>®</sup> capsules 2.5 µg) in 3,762 hemodialysis patients with intractable pruritus.

Kozono, Hideki; Yoshitani, Hiroshi; Nakano, Ryoko

Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch^® capsules 2.5 µg) in 3,762 hemodialysis patients with intractable pruritus.

Kozono, Hideki; Yoshitani, Hiroshi; Nakano, Ryoko.

Afiliación

Kozono H; Pharmaceutical and Medical Device Vigilance Department, Toray Industries, Inc., Tokyo, Japan.
Yoshitani H; Pharmaceutical and Medical Device Vigilance Department, Toray Industries, Inc., Tokyo, Japan.
Nakano R; Pharmaceutical and Medical Device Vigilance Department, Toray Industries, Inc., Tokyo, Japan.

Int J Nephrol Renovasc Dis ; 11: 9-24, 2018.

Article en En | MEDLINE | ID: mdl-29391822

Palabras clave

efficacy; hemodialysis; nalfurafine hydrochloride; post-marketing surveillance; pruritus; safety

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Screening_studies Aspecto: Patient_preference Idioma: En Revista: Int J Nephrol Renovasc Dis Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google